Skip to content
Pulsenmore home ultrasound black logo
  • Our technology

    This content is intended for healthcare professionals

    Home ultrasound

    For better access & continuity of care

    Partner with us

    To shape the future of prenatal care

    Specifications

    The technical side of things

    Publications

    You’ll be redirected to Pulsenmore’s global website, which includes indications not cleared for use in the United States

    FAQs

    Get answers to your questions

  • Resource center

    This content is intended for healthcare professionals

    Clinical resources

    You’ll be redirected to Pulsenmore’s global website, which includes indications not cleared for use in the United States

    Marketing collaterals

    Get to know more about Pulsenmore

    Events

    Stay updated with upcoming events

    Awards & recognition

    Award-winning company!

    News & press releases

    Important news we recently shared

    Newsletters

    Feel the PULSE and get all the updates

  • Investors

    About us

    Learn what patient centric care is all about

    Leadership

    Meet our board of directors and management team

    Careers

    Check out our current job openings

    Partners network

    Collaboration opportunities

    Investor relations

    Stay up to date with important news

  • Contact us
  • Consumers

    Patient portal

    Pulsenmore Home Ultrasound

    Reassurance, access to care and greater bonding

    Specifications

    The technical side of things

    FAQs

    Get answers to your questions

  • Australia
    • USA
    • UK
    • France
    • Germany
    • Spain
    • Portugal
    • Italy

Careers

Ramat-Gan
  • FP&A
    Finance · Full-time · Senior
  • נציג/ת מכירות ( טלפוניות ופרונטליות) וליווי לקוחות
    Marketing · Full-time · Intermediate

Important to know:

The Pulsenmore ES ultrasound system is FDA-authorized for prescribed use to support limited prenatal ultrasound imaging for determination of fetal heart rate in singleton pregnancies between 14–38 weeks of gestation. Images are reviewed and interpreted by a physician.The device is authorized for use by a single patient during a single pregnancy and is available only through authorized Pulsenmore representatives or qualified healthcare organizations. Use of the system does not replace diagnostic in-clinic ultrasound examinations.

footer-top-blue-bg

Let’s stay connected!

Facebook-icon X-icon Instagram_icon Linkedin-icon Tiktok-icon Youtube Icon
Pulsenmore expectant mom
footer-bottom-blue-bg
Pulsenmore home ultrasound black logo

Pulsenmore (NASDAQ, TASE: PLSM), a pioneer in connected home ultrasound, is on a mission to make accessible, patient-driven healthcare a reality.

Privacy policy
Consumer health data privacy policy
Legal
Terms of use for patients
Terms of use for clinicians
Security

Our solutions

Home Ultrasound
Specifications
Clinician dashboard
Publications
Partners network
Partners resource center
Careers

FAQs

Resource center

Clinical resources
Marketing materials
News & press releases
Awards & recognition

Newsletters

Events
FAQ

Investors

About us
Investor relations
Leadership

Consumers

About pulsenmore

Specifications

FAQ

Location

  • Australia
    • USA
    • UK
    • France
    • Germany
    • Spain
    • Portugal
    • Italy

Pulsenmore Offices, Israel
Corporate | 8 Omarim St., Omer
Central | 7 Derech Menahem Begin, Ramat Gan
Northern | 45 Derech Ha’atzmaut, Haifa
Americas LLC | 35 17th Street | Jericho | NY 11753

Site by WebCart

UX/Ui by 3bears

Privacy policy
Legal
Terms of Use
Clinician Terms of Use
Security

© 2026 Pulsenmore Ltd. This is the Pulsenmore global website. The Pulsenmore ES System is cleared for commercial distribution in select markets, including the United States, European Union, United Kingdom, Switzerland, Australia, Brazil, Colombia, and Israel. Product indications and intended use differ by region in accordance with local regulatory approvals.

Last updated August 2026
ISO 13485
iso-27799
ISO 27001
GDPR